Veracyte (VCYT)

Add to Watchlists
Create an Alert
13.05 -0.21  -1.58% NASDAQ Apr 15, 8:00PM BATS Real time Currency in USD
View Full Chart
VCYT Price Chart
View All Performance Charts

VCYT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Veracyte is up N/A over the last year vs S&P 500 Total Return up 18.46%, ANI Pharmaceuticals up 210.6%, and Celladon up N/A.

Get Quote for
Advertisement

Pro Strategies Featuring VCYT

Did Veracyte make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

VCYT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Veracyte Inc is engaged in the discovery, development and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.

Recent Quotes

Symbol Price Chg Chg % Market Cap
VCYT 13.05 -0.21 -1.58% 273.59M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.